A detailed history of Nomura Holdings Inc transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Nomura Holdings Inc holds 25,000 shares of TAK stock, worth $332,500. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25,000
Holding current value
$332,500
% of portfolio
0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$13.0 - $15.08 $325,000 - $377,000
25,000 New
25,000 $355,000
Q1 2024

May 15, 2024

BUY
$13.89 - $15.04 $233,352 - $252,672
16,800 New
16,800 $233,000
Q4 2023

Feb 14, 2024

BUY
$13.36 - $15.43 $2.77 Million - $3.2 Million
207,600 New
207,600 $2.96 Million
Q2 2023

Aug 14, 2023

BUY
$15.57 - $17.11 $5.67 Million - $6.23 Million
364,302 New
364,302 $5.72 Million
Q3 2022

Nov 15, 2022

BUY
$12.8 - $28.65 $1.65 Million - $3.68 Million
128,600 New
128,600 $1.67 Million
Q1 2021

May 17, 2021

SELL
$16.71 - $19.9 $3.59 Million - $4.28 Million
-215,000 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$15.39 - $18.97 $2 Million - $2.47 Million
130,000 Added 152.94%
215,000 $3.91 Million
Q3 2020

Nov 12, 2020

BUY
$17.1 - $19.19 $299,250 - $335,825
17,500 Added 25.93%
85,000 $1.52 Million
Q2 2020

Aug 14, 2020

SELL
$14.59 - $19.5 $510,650 - $682,500
-35,000 Reduced 34.15%
67,500 $1.22 Million
Q1 2020

May 15, 2020

BUY
$13.02 - $20.31 $1.33 Million - $2.08 Million
102,500 New
102,500 $1.55 Million
Q1 2020

May 14, 2020

SELL
$13.02 - $20.31 $1.56 Million - $2.44 Million
-120,000 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$16.88 - $20.83 $2.79 Million - $3.44 Million
-165,000 Reduced 57.89%
120,000 $2.37 Million
Q2 2019

Aug 14, 2019

SELL
$16.58 - $20.49 $1.95 Million - $2.41 Million
-117,500 Reduced 29.19%
285,000 $5.04 Million
Q1 2019

May 14, 2019

BUY
$16.7 - $21.52 $6.72 Million - $8.66 Million
402,500 New
402,500 $8.25 Million

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $41.4B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Nomura Holdings Inc Portfolio

Follow Nomura Holdings Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Holdings Inc with notifications on news.